Anjali Ganguli

Corporate Officer/Principal presso SYNDAX PHARMACEUTICALS, INC.

48 anni

Health Technology

Consumer Services

Profilo

Anjali Ganguli is currently the Chief Business Officer at Syndax Pharmaceuticals, Inc. She previously worked as the VP-Corporate Development at Regado Biosciences, Inc. from 2014 to 2015.
Dr. Ganguli completed her undergraduate degree at The University of Chicago and holds a doctorate from the University of Michigan.

Posizioni attive di Anjali Ganguli

Società	Posizione	Inizio
SYNDAX PHARMACEUTICALS, INC.	Corporate Officer/Principal	01/05/2015

Tutte le posizioni attive di Anjali Ganguli

Precedenti posizioni note di Anjali Ganguli

Società	Posizione	Fine
Regado Biosciences, Inc. Regado Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Regado Biosciences, Inc. is a biopharmaceutical company, which engages in the discovery and development of therapies in cardiovascular medicine using actively controlled aptamer technology. The company is focusing on new products for antithrombotic indications in the acute care and sub-acute care therapeutic setting. Its paired aptamer-active control agent technology is designed to give physicians the ability to directly control the degree of antithrombotic activity in real time on a "per patient, per setting" basis. The company's clinical programs are specifically concentrated on acute and sub-acute care injectable anticoagulants. Regado Biosciences was founded by Eli Gilboa, Bruce A. Sullenger and Christopher P. Rusconi on December 19, 2001 and is headquartered in Basking Ridge, NJ.	Corporate Officer/Principal	01/05/2015

Vedi nel dettaglio l'esperienza di Anjali Ganguli

Formazione di Anjali Ganguli

University of Michigan	Doctorate Degree
The University of Chicago	Undergraduate Degree

Esperienze
Posizioni ricoperte

Attive

Inattive

Società quotate in Borsa

Aziende private

Vedi nel dettaglio l'esperienza di Anjali Ganguli

Relazioni

Relazioni di 1° grado

Aziende connesse in 1º grado

Uomo

Donna

Amministratori

Dirigenti

Vedi i contatti personali

Società collegate

Società quotate in Borsa	1
SYNDAX PHARMACEUTICALS, INC.	Health Technology

Aziende private	1
Regado Biosciences, Inc. Regado Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Regado Biosciences, Inc. is a biopharmaceutical company, which engages in the discovery and development of therapies in cardiovascular medicine using actively controlled aptamer technology. The company is focusing on new products for antithrombotic indications in the acute care and sub-acute care therapeutic setting. Its paired aptamer-active control agent technology is designed to give physicians the ability to directly control the degree of antithrombotic activity in real time on a "per patient, per setting" basis. The company's clinical programs are specifically concentrated on acute and sub-acute care injectable anticoagulants. Regado Biosciences was founded by Eli Gilboa, Bruce A. Sullenger and Christopher P. Rusconi on December 19, 2001 and is headquartered in Basking Ridge, NJ.	Health Technology